Home > Name List By e > Eptifibatide

CAS No 188627-80-7 , Eptifibatide

  • Name: Eptifibatide
  • Synonyms: N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2; N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Eptifibatide; INTEGRELIN;
  • CAS Registry Number:
  • Density: 1.605 g/cm3
  • Refractive index: 1.735
  • Molecular Weight: 831.96
  • InChI: InChI=1/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)
  • Molecular Formula: C35H49N11O9S2
  • Molecular Structure:CAS No:188627-80-7 Eptifibatide

Related products

Search by region :

Select to

188627-80-7 Eptifibatide

  • China Sinopep Pharmaceutical Inc [Manufacturers]
  • Tel: +86-571-28918377
  • Fax: +86-571-28918368
  • Address: Room 3B01-3B03,No.452,6th street,Eco.&Tech.Development Zone, Hangzhou Zhejiang,China Hangzhou,ZhejiangChina
Contact Supplier

188627-80-7 Eptifibatide

  • China Hwasun Biotechnology Co., Ltd [Manufacturers]
  • Tel: +86-21-64764896 64764113
  • Fax: +86-21-64765024
  • Address: Rm.411,415 Bldg. 2 No.2715 Longwu Rd., Xuhui Dist, Shanghai China 200231 null,ShanghaiChina
Contact Supplier

188627-80-7 Eptifibatide

  • China Shanghai C-Strong Co., Ltd. [Manufacturers]
  • Tel: +86-(21)-6095-7549
  • Fax: +86-(21)-6095-7549
  • Address: Room 902, No.2075 Kongjiang Road, Shanghai 200092, Shanghai,ShanghaiChina
Contact Supplier

188627-80-7 Eptifibatide

  • China Sinopep Pharmaceutical Inc. [Manufacturers]
  • Tel: +86-(571)-28918380
  • Fax: +86-(571)-28918368
  • Address: No.1180 Bin'an Road, New and High-tech Development Zone, Hangzhou, Hangzhou,ZhejiangChina
Contact Supplier

188627-80-7 Eptifibatide

Contact Supplier

188627-80-7 Eptifibatide

  • China Sunbow Biotech Co., Ltd [Manufacturers]
  • Tel: +86-(755)-26100037
  • Fax: +86-(755)-83481591
  • Address: A-01, South International Plaza, YiTian Road, ShenZhen, Guangdong 518048, shenzhen,GDChina
Contact Supplier

Select to

4/4
Previous 1 2 3 4
References of Eptifibatide
Title: Eptifibatide
CAS Registry Number: 188627-80-7
CAS Name: N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic (1?6)-disulfide
Trademarks: Integrilin (COR)
Molecular Formula: C35H49N11O9S2
Molecular Weight: 831.96
Percent Composition: C 50.53%, H 5.94%, N 18.52%, O 17.31%, S 7.71%
Literature References: Fibrinogen receptor antagonist. Specifically inhibits fibrinogen binding to the platelet integrin GPIIb-IIIa which prevents platelet aggregation and subsequent clot formation. Synthetic, disulfide-linked cyclic heptapeptide based on barbourin, a specific GPIIb-IIIa antagonist isolated from venom of the southeastern pigmy rattlesnake, Sistrurus m. barbouri. Contains the Lys-Gly-Asp (KGD) amino acid sequence, a modification of the Arg-Gly-Asp (RGD) recognition site which appears to confer specificity: R. M. Scarborough et al., J. Biol. Chem. 266, 9359 (1991). Design and structure-activity study of integrin antagonists: eidem, ibid. 268, 1066 (1993). Prepn: R. M. Scarborough et al., US 5686570 (1997 to COR Therapeutics). Pharmacology: F. A. Nicolini et al., Circulation 89, 1802 (1994); K. Uthoff et al., ibid. 90, pt 2, II-269 (1994). Clinical trial in patients undergoing percutaneous cardiovascular intervention: IMPACT-II Investigators, Lancet 349, 1422 (1997). Clinical trial in acute coronary syndromes: PURSUIT Trial Investigators, N. Engl. J. Med. 339, 436 (1998).
Therap-Cat: Antithrombotic.
Keywords: Antithrombotic.